Tay Therapeutics
PrivateLast Round
Grant
Oct 1, 2023
Total Funding Raised
$430,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tay Therapeutics is a biotechnology company that develops targeted small molecule therapies for inflammatory conditions and rare genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tay Therapeutics Comparables
Compare Tay Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nonsense Therapeutics | 92% | |
| Eloxx Pharmaceuticals, Inc. | 77% | |
| Anima Biotech | 73% |
Tay Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2023 | ||||
| VC Round | Nov 2, 2021 | ||||
| Seed | Nov 27, 2020 |
Key People
Founding team and executive leadership
Tay Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| o2h ventures | Seed, VC Round |
| Meltwind Advisory | Seed, VC Round |
| Innovate UK | Grant |
| Wren Capital | Seed, VC Round |
| Scottish Investment Bank (Scottish Enterprise) | Seed, VC Round |
| University of Dundee | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 51% MoM, reaching 1.1K.
- Oct 1, 2023
$430K grant received from Innovate UK.
Tay Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tay Therapeutics's valuation, stock price, and market status.
Is Tay Therapeutics a public or private company?
Tay Therapeutics is a private company.
What is the current stock price of Tay Therapeutics?
Tay Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Tay Therapeutics worth (valuation)?
Valuation information for Tay Therapeutics is not publicly available.
Can I buy Tay Therapeutics stock?
Tay Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tay Therapeutics's last funding round?
Tay Therapeutics's most recent funding round was Grant on October 1, 2023.
Who are the main investors in Tay Therapeutics?
Key investors in Tay Therapeutics include o2h ventures.
Will Tay Therapeutics IPO soon?
No public IPO plans have been announced for Tay Therapeutics.
How can I track Tay Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tay Therapeutics's secondary market activity and sign up for updates.